John P. Mulhall, MD, discusses the significant sexual and nonsexual adverse events of low testosterone resulting from using androgen deprivation therapy (ADT) to treat men with prostate cancer. He emphasizes the need for physicians to counsel patients on longterm expectations and to obtain fullyinformed consent prior to the initiation of this therapy.

Read more here: https://grandroundsinurology.com/test...